Neuphoria Therapeutics Inc. Insider Trading

NEUP

⊜ Compare

Last 12 months

No open-market buying or selling by insiders.

No executive or director has bought shares on the open market in the last two years.

Net open-market

0 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

0 / 0

executives and directors

Last open-market buy

None

in the last two years

Get an email when NEUP's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 21, 2025	Lynx1 Capital Management LP Large holder	Bought	639,110	$5.14	$3.29M	271%	Form 4

Oct 21, 2025
Lynx1 Capital Management LP
Large holder · bought 639,110 at $5.14
$3.29M
271% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch NEUP, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with NEUP

CompareIntrinsic value

LGVNLongeveron Inc.

$1.78+0.00%10

IGCIGC Pharma Inc.

$0.20+5.26%26

VTGNVistaGen Therapeutics Inc.

$0.18+5.88%10

ORGSOrgenesis Inc.

$0.05+0.00%20

SXTP60 Degrees Pharmaceuticals Inc.

$0.96-5.32%40

STTKShattuck Labs Inc.

$5.29-3.38%40

DAREDare Bioscience Inc.

$0.66+1.83%10

RFLRafael Holdings Inc.

$1.07-0.93%40

Held by ETFs

NEUP is in 1 US ETF. The largest of them, with NEUP's weight in each:

PSAdvisorShares Psychedelics ETFPSIL2.49%of the fund

Spot a number that looks wrong? Check it in NEUP's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing NEUP

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.